Who
Donald E. Morel Jr.
Director
Company insider
Files Form 4 as: Director, Stevanato Group S.p.A; Director, Catalent; Director, Integra LifeSciences Holdings; Chair of the Board & CEO, West Pharmaceutical Services; Director, Kensey Nash.
In numbers
- Trades disclosed
- 398
- Buys
- 5
- Sells
- 21
- Bought
- $1.7M
- Sold
- $9.8M
- Companies
- 5
- Companies where not an officer
- 4
- First trade
- 7 Mar 2005
- Last trade
- 15 Jun 2026
- Last filed
- 26 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 15 Jun 2026filed 26 Jun 2026 | STVN Stevanato Group S.p.AMedical Devices | SEC FORM 4 Sold | $26K1,493 at $17.09 | filing |
| 15 Jun 2026filed 26 Jun 2026 | STVN Stevanato Group S.p.AMedical Devices | SEC FORM 4 Sold | $26K1,493 at $17.09 | filing |
| 12 Jun 2026filed 26 Jun 2026 | STVN Stevanato Group S.p.AMedical Devices | SEC FORM 4 Code A | —4,975 at $0.00 | filing |
| 12 Jun 2026filed 26 Jun 2026 | STVN Stevanato Group S.p.AMedical Devices | SEC FORM 4 Code A | —4,975 at $0.00 | filing |
| 18 Dec 2024filed 18 Dec 2024 | Catalent | SEC FORM 4 Code D | —70,118 | filing |
| 30 Oct 2024filed 1 Nov 2024 | Catalent | SEC FORM 4 Code A | —4,663 at $0.00 | filing |
| 27 Oct 2023filed 31 Oct 2023 | Catalent | SEC FORM 4 Code A | —6,993 at $0.00 | filing |
| 27 Oct 2022filed 31 Oct 2022 | Catalent | SEC FORM 4 Code A | —4,149 at $0.00 | filing |
| 13 May 2022filed 17 May 2022 | IART Integra LifeSciences HoldingsMedical Devices | SEC FORM 4 Code A | —3,456 at $0.00 | filing |
| 28 Oct 2021filed 1 Nov 2021 | Catalent | SEC FORM 4 Code A | —1,402 at $0.00 | filing |
| 14 May 2021filed 17 May 2021 | IART Integra LifeSciences HoldingsMedical Devices | SEC FORM 4 Code A | —530 at $0.00 | filing |
| 14 May 2021filed 17 May 2021 | IART Integra LifeSciences HoldingsMedical Devices | SEC FORM 4 Code A | —2,896 at $0.00 | filing |
| 29 Oct 2020filed 2 Nov 2020 | Catalent | SEC FORM 4 Code A | —2,125 at $0.00 | filing |
| 27 Aug 2020filed 28 Aug 2020 | Catalent | SEC FORM 4 Code A | —661 at $0.00 | filing |
| 13 May 2020filed 15 May 2020 | IART Integra LifeSciences HoldingsMedical Devices | SEC FORM 4 Code A | —791 at $0.00 | filing |
| 13 May 2020filed 15 May 2020 | IART Integra LifeSciences HoldingsMedical Devices | SEC FORM 4 Code A | —4,218 at $0.00 | filing |
| 22 Aug 2019filed 26 Aug 2019 | Catalent | SEC FORM 4 Code A | —3,167 at $0.00 | filing |
| 16 May 2019filed 20 May 2019 | IART Integra LifeSciences HoldingsMedical Devices | SEC FORM 4 Code A | —3,785 at $0.00 | filing |
| 15 May 2019filed 16 May 2019 | Catalent | SEC FORM 4 Bought | $444K10,000 at $44.44 | filing |
| 13 Sep 2018filed 17 Sep 2018 | Catalent | SEC FORM 4 Bought | $430K10,000 at $43.00 | filing |
News
Stevanato Group S.p.A. (NYSE:STVN) Receives Average Rating of "Moderate Buy" from BrokeragesSTVN · dailypolitical.com · 6 Oct 2026Financial Contrast: Bionano Genomics (NASDAQ:BNGO) and Stevanato Group (NYSE:STVN)STVN · themarketsdaily.com · 6 Oct 2026
0 headlines in the last 90 days name Donald E. Morel Jr.; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.